BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 30370535)

  • 1. Multiomics analysis on DNA methylation and the expression of both messenger RNA and microRNA in lung adenocarcinoma.
    Yang Z; Liu B; Lin T; Zhang Y; Zhang L; Wang M
    J Cell Physiol; 2019 May; 234(5):7579-7586. PubMed ID: 30370535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel genome-wide DNA methylation profiling reveals distinct epigenetic landscape, prognostic model and cellular composition of early-stage lung adenocarcinoma.
    Gan J; Huang M; Wang W; Fu G; Hu M; Zhong H; Ye X; Cao Q
    J Transl Med; 2024 May; 22(1):428. PubMed ID: 38711158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant Methylation and Differential Expression of SLC2A1, TNS4, GAPDH, ATP8A2, and CASZ1 Are Associated with the Prognosis of Lung Adenocarcinoma.
    Wang X; Shi D; Zhao D; Hu D
    Biomed Res Int; 2020; 2020():1807089. PubMed ID: 33029490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of GCLC in prognosis and immunity of lung adenocarcinoma and multi-omics regulation mechanisms.
    Huang Z; Liang F; Wu J; Huang Z; Li Y; Huang X; Liu Z
    BMC Pulm Med; 2024 May; 24(1):239. PubMed ID: 38750474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-omics analysis reveals epigenetically regulated processes and patient classification in lung adenocarcinoma.
    Brativnyk A; Ankill J; Helland Å; Fleischer T
    Int J Cancer; 2024 Jul; 155(2):282-297. PubMed ID: 38489486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated whole-exome and bulk transcriptome sequencing delineates the dynamic evolution from preneoplasia to invasive lung adenocarcinoma featured with ground-glass nodules.
    Zhou D; Li YQ; Liu QX; Deng XF; Chen L; Li MY; Zhang J; Lu X; Zheng H; Dai JG
    Cancer Med; 2024 Jun; 13(11):e7383. PubMed ID: 38864483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of tumor related signaling pathways with known compounds to determine potential agents for lung adenocarcinoma.
    Xu S; Liu R; Da Y
    Thorac Cancer; 2018 Aug; 9(8):974-988. PubMed ID: 29870138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining single-cell RNA sequencing data and transcriptomic data to unravel potential mechanisms and signature genes of the progression of idiopathic pulmonary fibrosis to lung adenocarcinoma and predict therapeutic agents.
    Zhou X; Tan F; Zhang S; Zhang T
    Funct Integr Genomics; 2023 Nov; 23(4):346. PubMed ID: 37996625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel candidate key drivers in the integrative network of genes, microRNAs, methylations, and copy number variations in squamous cell lung carcinoma.
    Huang T; Yang J; Cai YD
    Biomed Res Int; 2015; 2015():358125. PubMed ID: 25802847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-omics analysis of MRPL-13 as a tumor-promoting marker from pan-cancer to lung adenocarcinoma.
    Zhong X; He Z; Fan Y; Yin L; Hong Z; Tong Y; Bi Q; Zhu S
    Aging (Albany NY); 2023 Oct; 15(19):10640-10680. PubMed ID: 37827692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering lung adenocarcinoma evolution: Integrative single-cell genomics identifies the prognostic lung progression associated signature.
    Zhang P; Yang Z; Liu Z; Zhang G; Zhang L; Zhang Z; Fan J
    J Cell Mol Med; 2024 Jun; 28(11):e18408. PubMed ID: 38837585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA‑mediated regulation in lung adenocarcinoma: Signaling pathways and potential therapeutic implications (Review).
    Liu J; Zhang F; Wang J; Wang Y
    Oncol Rep; 2023 Dec; 50(6):. PubMed ID: 37859595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FAM86A methylation of eEF2 links mRNA translation elongation to tumorigenesis.
    Francis JW; Hausmann S; Ikram S; Yin K; Mealey-Farr R; Flores NM; Trinh AT; Chasan T; Thompson J; Mazur PK; Gozani O
    Mol Cell; 2024 May; 84(9):1753-1763.e7. PubMed ID: 38508183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of multi-omics data for survival prediction of lung adenocarcinoma.
    Guo D; Wang Y; Chen J; Liu X
    Comput Methods Programs Biomed; 2024 Jun; 250():108192. PubMed ID: 38701699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A feature selection-based framework to identify biomarkers for cancer diagnosis: A focus on lung adenocarcinoma.
    Abdelwahab O; Awad N; Elserafy M; Badr E
    PLoS One; 2022; 17(9):e0269126. PubMed ID: 36067196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myo1e overexpression in lung adenocarcinoma is associated with increased risk of mortality.
    Jusue-Torres I; Tiv R; Ricarte-Filho JC; Mallisetty A; Contreras-Vargas L; Godoy-Calderon MJ; Khaddour K; Kennedy K; Valyi-Nagy K; David O; Menchaca M; Kottorou A; Koutras A; Dimitrakopoulos F; Abdelhady KM; Massad M; Rubinstein I; Feldman L; Stewart J; Shimamura T; Danilova L; Hulbert A
    Sci Rep; 2023 Mar; 13(1):4107. PubMed ID: 36914720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multi-omics approach for biomarker discovery in neuroblastoma: a network-based framework.
    Hussein R; Abou-Shanab AM; Badr E
    NPJ Syst Biol Appl; 2024 May; 10(1):52. PubMed ID: 38760476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological and clinical significance of the glypican-3 gene in human lung adenocarcinoma: An in silico analysis.
    Imon RR; Aktar S; Morshed N; Nur SM; Mahtarin R; Rahman FA; Talukder MEK; Alam R; Karpiński TM; Ahammad F; Zamzami MA; Tan SC
    Medicine (Baltimore); 2023 Nov; 102(45):e35347. PubMed ID: 37960765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterations.
    Kaneko S; Takasawa K; Asada K; Shiraishi K; Ikawa N; Machino H; Shinkai N; Matsuda M; Masuda M; Adachi S; Takahashi S; Kobayashi K; Kouno N; Bolatkan A; Komatsu M; Yamada M; Miyake M; Watanabe H; Tateishi A; Mizuno T; Okubo Y; Mukai M; Yoshida T; Yoshida Y; Horinouchi H; Watanabe SI; Ohe Y; Yatabe Y; Saloura V; Kohno T; Hamamoto R
    Mol Cancer; 2024 Jun; 23(1):126. PubMed ID: 38862995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylated SHMT2 Regulates Oncogenesis Through m
    Han T; Wang Y; Cheng M; Hu Q; Wan X; Huang M; Liu Y; Xun W; Xu J; Wang L; Luo R; Yuan Y; Wang K; Wang J
    Adv Sci (Weinh); 2024 May; 11(18):e2307834. PubMed ID: 38460155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.